Skip to content
The Roadmap

We know exactly where we're going. Here's the plan.

Every milestone is backed by research, clinical partnerships, and a funding strategy designed to scale.

16-Month Commercial Roadmap
TO AUG 2026

Prototype Completion

Final RevoStep engineering refinements. SolidWorks design finalization and component manufacturing.

AUG–SEP 2026

IdeaBUILD Prototype Days

Public demonstrations. Early adopter feedback. Clinical partner outreach.

OCT–NOV 2026

Kinesiology Lab Experiments

Controlled biomechanical data collection with Dr. McGibbon's cohort at UNB.

APR 2027

Clinical Trial Launch (planned)

20-subject controlled trial in development with UNB, subject to finalized protocol, funding, institutional agreement, and research ethics approval.

JUL 2027

Manufacturing (planned)

Design-for-manufacturing engagement toward scale production.

AUG 2027

Health Canada MDEL Application

Medical Device Establishment License application submitted.

Funding Strategy

$344K projected spend. $120K grant-eligible.

Mitacs Accelerate

Research internship funding with the UNB CARE Lab. Proposal in development.

NSERC Alliance

Academic-industry research partnership grants. A program we intend to pursue.

NRC-IRAP

Industrial research and innovation assistance. Enrollment confirmed; funding scope under negotiation.

SR&ED

Scientific Research & Experimental Development tax credits — retrospective, claimed after qualifying spend rather than received upfront.

Non-dilutive programs we intend to pursue alongside the round. None are secured, and they are not guaranteed to stack.

Be part of what comes next.

LimbRise is opening a $550,000 seed round in September 2027. The engineering, validation, and regulatory work leading up to it is already in motion.